Myriad Genetics Inc
Statements
Cash Flow
Myriad Genetics Inc (MYGN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -8.3 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -2.9 | 31 | 41 | 37 | 24 | 33 | 12 | 48 | 7.8 | 38 | 6.6 | 32 | 16 | -1.9 | 17 | 30 | -59 | -14 | 72 | -4.4 | -39 | -9.9 | -47 | -50 | -2.8 | -7.7 | -33 | -0.9 | -22 | -55 | -19 | 2.6 | 0.7 | 6.6 | -16 | -14 | 21 | 11 | -16 | -8.3 | 7.7 | |
| 9.2 | 13 | 13 | 13 | 13 | 13 | 13 | 15 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 17 | 14 | 13 | 13 | 13 | 13 | 17 | 19 | 13 | 14 | 15 | 16 | 15 | 15 | 15 | 14 | 14 | 13 | 13 | 13 | 13 | 50 | |
| 7.8 | 7.4 | 7.5 | 7.2 | 6.4 | 6.9 | 6.7 | 7.1 | 7.7 | 7.5 | 9.5 | 8.8 | 8.8 | 7.0 | 7.5 | 1.9 | 8.4 | 6.5 | 9.0 | 8.9 | 10 | 8.4 | 10 | 10 | 9.4 | 8.2 | 7.5 | 11 | 12 | 10 | 12 | 15 | 12 | 11 | 9.5 | 11 | 12 | 2.8 | 6.5 | 7.2 | 29 | |
| 19 | 19 | 21 | 14 | -47 | -1.0 | 8.3 | 15 | 7.7 | 6.3 | 12 | 25 | 4.4 | 6.7 | 91 | -31 | 56 | 9.0 | -1.7 | -10 | -131 | 1.5 | 18 | 8.1 | 12 | 16 | 26 | 2.8 | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| -30 | -5.9 | 2.7 | -3.5 | -13 | -2.0 | 9.0 | 13 | -15 | 11 | -24 | -9.0 | 10 | -16 | 23 | 97 | -135 | 45 | 91 | -4.9 | 53 | -17 | -57 | -57 | 7.4 | 4.7 | -24 | 99 | -6.5 | -41 | -21 | -2.3 | -7.3 | -24 | -12 | -27 | 21 | -1.6 | -8.2 | 13 | 25 | |
| 1.5 | 2.4 | 1.5 | 0.7 | 1.6 | 2.1 | 2.9 | 1.8 | 1.3 | 2.8 | 3.1 | 1.4 | 1.4 | 3.4 | 3.0 | 2.4 | 1.5 | 6.3 | 7.1 | 4.5 | 3.0 | 3.4 | 6.3 | 6.7 | 18 | 15 | 24 | 19 | 18 | 14 | 8.6 | 5.2 | 3.5 | 5.9 | 5.3 | 6.9 | 2.8 | 6.0 | 5.4 | 2.1 | 16 | |
| -158 | -2.1 | 9.5 | 4.3 | -15 | -4.6 | -0.7 | 8.9 | -279 | -8.1 | -3.8 | 4.5 | -7.1 | -7.2 | 25 | 10 | 17 | 11 | 8.2 | 1.1 | 291 | -26 | -41 | -12 | 11 | -36 | 35 | 12 | -2.5 | -12 | -7.1 | -6.4 | 7.5 | -5.9 | -8.3 | -6.9 | -6.2 | -6.0 | -6.5 | -3.2 | -22 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 26 | 0.0 | – | – | 41 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| -21 | -10 | 0.0 | 0.0 | 0.0 | 0.3 | 0.2 | -32 | 0.0 | -50 | -44 | -50 | -0.4 | 1.3 | 1.5 | – | – | – | 27 | – | – | – | – | – | -3.8 | – | -4.9 | -0.2 | -2.2 | – | – | – | -3.0 | – | – | – | -0.3 | – | – | – | – | |
| 199 | 3.4 | -37 | -68 | -25 | -31 | 26 | -60 | 250 | 15 | -11 | -30 | -8.6 | – | – | -1.0 | -71 | -71 | -71 | -50 | -106 | – | – | – | 40 | 40 | 40 | 40 | – | – | – | – | -0.1 | 0.4 | 19 | -0.1 | 65 | 0.1 | -0.1 | -0.2 | 65 | |
| 176 | -4.0 | -37 | -63 | -23 | -26 | -4.3 | -41 | 252 | -33 | -9.4 | -28 | -12 | 1.1 | 0.2 | 1.0 | -3.9 | 1.7 | -49 | -27 | -75 | -1.1 | -4.8 | 2.5 | -3.6 | -2.1 | -4.9 | 38 | -2.5 | 122 | -8.8 | 2.4 | -3.1 | 2.1 | 14 | 2.6 | 56 | -8.2 | -3.0 | 2.2 | 47 | |
| 18 | 21 | 16 | -21 | -15 | 0.8 | 8.7 | 14 | -18 | -2.7 | -5.7 | 8.3 | -3.3 | -8.7 | 40 | 43 | -45 | 45 | 32 | -31 | 177 | -37 | -93 | -59 | 4.5 | -52 | -3.3 | 50 | -28 | 56 | -35 | -4.5 | 7.5 | 2.1 | -11 | -17 | 71 | -3.5 | -25 | -9.2 | 33 | |
| -4.4 | 29 | 40 | 36 | 22 | 31 | 8.6 | 46 | 6.5 | 35 | 3.5 | 30 | 14 | -5.3 | 14 | 28 | -61 | -21 | 65 | -8.9 | -42 | -13 | -53 | -56 | -21 | -22 | -57 | -20 | -40 | -68 | -27 | -2.6 | -2.8 | 0.7 | -22 | -21 | 18 | 4.6 | -21 | -10 | -8.6 |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.